Fundraising Fox
Kanvas Bio
Monmouth Junction, US · Founded 2020 · 42 employees on LinkedIn · 12 known investors
Find your way into Kanvas Bio
Sign up to see every warm intro you have to Kanvas Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kanvas Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kanvas Bio operates a platform for discovering, developing, and manufacturing live biotherapeutics based on the human gut microbiome. It combines high-resolution host-microbiome mapping with large-scale anaerobic co-culture manufacturing to support drug development for pharmaceutical and biotechnology partners.
Founders & leadership
Kanvas Bio was founded in 2020 by Matthew Cheng, Hao Shi, and Iwijn De Vlaminck.
Board
Investors · 12
How we know: a partner's Signal profile · av.vc · Not right? Tell us
How we know: Bascom Ventures's portfolio page · Not right? Tell us
How we know: Boutique Venture Partners's portfolio page · Not right? Tell us
How we know: DCVC (Data Collective)'s portfolio page · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: FemHealth Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Germin8 Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pangaea Ventures Us Inc.'s portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.7M disclosed across 2 rounds · 2023–2024
▶$3.9MraisedMar 2024 · 54 investors · Other Health CareRule 506(b)
- Paul TheunissenDirector
- Jason PontinDirector
- Matthew ChengExecutive Officer, Director
- Hao ShiExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $3.9M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$11.8MraisedJun 2023 · 12 investors · Other Health CareRule 506(b)
- Jason PontinDirector
- Matthew ChengExecutive Officer, Director
- Hao ShiExecutive Officer, Director
- Iwijn De VlaminckExecutive Officer, Director
- Justin SmithlineDirector
- Offering amount
- $12M
- Amount sold
- $11.8M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Kanvas Bio went on to found or lead other companies.
Frequently asked questions
- What does Kanvas Bio do?
- Kanvas Bio operates a platform for discovering, developing, and manufacturing live biotherapeutics based on the human gut microbiome. It combines high-resolution host-microbiome mapping with large-scale anaerobic co-culture manufacturing to support drug development for pharmaceutical and biotechnology partners.
- Who founded Kanvas Bio?
- Kanvas Bio was founded by Matthew Cheng, Hao Shi, Iwijn De Vlaminck in 2020.
- Who are Kanvas Bio's investors?
- Kanvas Bio's investors include Alumni Ventures, Bascom Ventures, Boutique Venture Partners, DCVC (Data Collective), FemHealth Ventures, Germin8 Ventures, Kicker Ventures, Mana Ventures and 4 more.
- How much funding has Kanvas Bio raised?
- Kanvas Bio has disclosed $15.7M raised across 2 rounds.
- Where is Kanvas Bio headquartered?
- Kanvas Bio is headquartered in Monmouth Junction, US.